CAMERON COLLIER: Open Payments
NPI 1255056446 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,087 in 177 payments from 21 companies in 2025. Trend: 2023 $2,059 · 2024 $2,759 · 2025 $3,087
Food & beverage: $2,863Education: $224
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $479 |
| Janssen Biotech, Inc. | 13 | $455 |
| Galderma Laboratories, L.P. | 32 | $401 |
| UCB, Inc. | 23 | $379 |
| ABBVIE INC. | 28 | $372 |
| E.R. Squibb & Sons, L.L.C. | 31 | $315 |
| Amgen Inc. | 9 | $139 |
| LEO Pharma Inc. | 6 | $99 |
| Lilly USA, LLC | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, Sotyktu, RINVOQ, SKYRIZI, OTEZLA.
Industry payments across KY — which companies pay providers there.
